Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 44 | 44 | 44 | 159 | 44 |
| Gross Profit | 44 | 44 | 44 | 159 | 44 |
| Operating Expenses | 8,043 | 6,434 | 5,434 | 4,969 | 5,422 |
| Operating Income | -7,999 | -6,390 | -5,390 | -4,810 | -5,379 |
| Other Income | -5,806 | 212 | -1,549 | 29 | -222 |
| Pre-tax Income | -13,805 | -6,178 | -6,940 | -4,781 | -5,601 |
| Net Income Continuous | -13,805 | -6,178 | -6,940 | -4,781 | -5,601 |
| Minority Interests | -113 | -99 | -182 | -167 | -287 |
| Net Income | $-13,692 | $-6,079 | $-6,758 | $-4,614 | $-5,314 |
| EPS Basic Total Ops | -0.33 | -0.23 | -0.41 | -0.33 | -0.44 |
| EPS Basic Continuous Ops | -0.33 | -0.24 | -0.42 | -0.33 | -0.44 |
| EPS Diluted Total Ops | -0.33 | -0.23 | -0.41 | -0.33 | -0.44 |
| EPS Diluted Continuous Ops | -0.33 | -0.24 | -0.42 | -0.33 | -0.44 |
| EBITDA(a) | $-7,554 | $-5,890 | $-4,905 | $-4,360 | $-4,901 |